Soyabean oil-filled breast implants withdrawn from UK market
This article was originally published in Clinica
Trilucent soyabean oil-filled breast implants have been withdrawn from the UK market on the advice of the Medical Devices Agency (MDA). A small number of women have reported local complications, including swelling generally associated with implant rupture.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.